Related references
Note: Only part of the references are listed.Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours
W. H. Y. Ling et al.
BRITISH JOURNAL OF CANCER (2013)
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz et al.
LANCET (2013)
Progressive liver failure induced by everolimus for renal cell carcinoma in a 58-year-old male hepatitis B virus carrier
Shinta Mizuno et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2013)
Hepatitis B reactivation related to everolimus
Sema Sezgin Goksu et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin
Kris V. Kowdley et al.
HEPATOLOGY (2012)
Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy
Makoto Oketani et al.
HEPATOLOGY RESEARCH (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma
Camillo Porta et al.
EUROPEAN JOURNAL OF CANCER (2011)
Novel Feedback Inhibition of Surface Antigen Synthesis by Mammalian Target of Rapamycin (mTOR) Signal and Its Implication for Hepatitis B Virus Tumorigenesis and Therapy
Chiao-Fang Teng et al.
HEPATOLOGY (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy
Maria Luisa Manzano-Alonso et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Reactivation of Hepatitis B Virus After Rituximab-Containing Treatment in Patients With CD20-Positive B-Cell Lymphoma
Kosei Matsue et al.
CANCER (2010)
American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
Andrew S. Artz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis.
Darcy A. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Reactivation of Hepatitis B
Jay H. Hoofnagle
HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Robert J. Motzer et al.
LANCET (2008)
Prophylaxis and treatment of hepatitis B in immunocompromised patients
A. Marzano et al.
DIGESTIVE AND LIVER DISEASE (2007)
Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection
M Onozawa et al.
TRANSPLANTATION (2005)
Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation
A Knöll et al.
BONE MARROW TRANSPLANTATION (2004)
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
W Yeo et al.
BRITISH JOURNAL OF CANCER (2004)
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study
W Yeo et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Share Paper
